查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1948892

生物工艺袋市场按产品类型、材料类型、成分、灭菌方法、应用和最终用户划分，全球预测（2026-2032）

Bioprocess Bags Market by Product Type, Material Type, Configuration, Sterilization Method, Application, End User - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 192 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

预计到 2025 年，生物加工袋市场价值将达到 45.8 亿美元，到 2026 年将成长至 50.9 亿美元，到 2032 年将达到 112.4 亿美元，复合年增长率为 13.67%。

关键市场统计数据
基准年 2025 45.8亿美元
预计年份：2026年 50.9亿美元
预测年份 2032 112.4亿美元
复合年增长率 (%) 13.67%

现代生物加工袋技术及其关键设计挑战的简要概述：连接材料、灭菌和生产灵活性

生物製药生产中一次性技术的演进，已使生物製程袋从辅助耗材跃升为实现柔软性、扩充性且污染可控生产的关键要素。本文概述了当前的技术格局，将材料科学的进步、组件设计方案、灭菌要求和监管预期与营运重点（例如最大限度地减少停机时间、降低交叉污染风险以及实现快速产品切换）联繫起来。

新兴的技术和程序趋势正在重塑生物製药生产中的生物製程袋材料、灭菌方法和配置选择。

生物製程袋技术正经历变革性的转变，这主要得益于聚合物工程、灭菌能力以及主导配置偏好等方面的突破性进展。高性能聚乙烯和聚丙烯复合材料的创新，结合多层共挤出和增强焊接技术，在提高机械强度和耐化学性的同时，简化了无菌转移操作。这些材料和製程的创新在许多情况下减少了对刚性管道系统的需求，并实现了更模组化、分散式的生产模式。

即将到来的关税调整促使供应链重新设计、考虑近岸外包以及重新评估筹资策略，以确保生物製药生产的连续性。

美国计划于2025年实施的新关税迫使生物製药生产商和供应商重新评估其供应链韧性、筹资策略和成本转嫁机制。关税导致的进口成本调整给供应商选择、库存缓衝和原材料采购地域多元化等决策週期带来了压力。对于依赖进口薄膜、配件或成品包装袋的生产商而言，这些关税正促使他们紧急评估近岸外包、双重采购和库存优化策略，以维持生产的连续性。

从分析观点探讨销售细分、产品类型、应用、最终用户、材料科学、成分和灭菌方法等因素如何影响采购和验证路径。

详细的細項分析揭示了不同容量等级、产品类型、最终用途和材料之间的差异，这些差异都会影响采购、验证和库存策略。容量类别涵盖从超小容量包装（0-10公升）、中等容量包装（10-50公升）到大容量包装（>50公升），这些类别不仅决定了搬运和储存方法，还决定了连接器的选择和製程放大计划。小容量包装通常与研发和临床工作流程相关，在这些流程中，柔软性和快速週转是优先考虑的因素；而大容量包装则适用于商业规模的生产，但也带来了独特的物流和储存挑战。

区域製造地、管理体制和供应链基础设施如何驱动全球生物加工袋市场中差异化的实施和筹资策略

区域趋势正在以不同的方式影响美洲、欧洲、中东和非洲以及亚太地区的供应链结构、监管应对措施以及技术采纳速度。在美洲，接近性主要生物技术丛集以及成熟的契约製造生态系统推动了先进一次性系统的高采纳率，并促使企业优先选择能够提供完善验证方案的供应商。该地区重视快速推进临床试验，而完善的物流基础设施则有助于快速分发袋组件和替换零件。

技术差异化、垂直整合和服务导向伙伴关係如何定义产业竞争优势和供应商选择标准

生物加工袋领域的竞争格局呈现出技术差异化、垂直整合、策略伙伴关係以及服务主导价值提案结合的特征。领先的供应商若投资于聚合物科学、检验的灭菌通讯协定以及全面的可萃取物和可浸出物数据，便能构建起稳固的市场地位，从而吸引那些受到严格监管的终端用户。同时，那些将上游工程薄膜挤出与下游加工能力相结合的公司，能够提供更短的前置作业时间和更完善的品管，为重视供应连续性的客户提供极具吸引力的提案。

透过增强供应链韧性、加快验证准备速度和扩展服务能力，实际降低风险并提高客户维繫留存率。

产业领导者应抓住机会，同时采取三项策略以降低中断风险：增强供应链韧性、提升技术验证能力、深化客户服务模式。首先，透过对多家地理位置分散的薄膜和加工合作伙伴进行资质认证，并探索关键零件的近岸外包机会，实现供应链多元化，从而降低关税和物流风险。此外，还应制定策略性库存政策，优化长前置作业时间物料的缓衝库存，同时避免不必要的营运资金负担。

我们采用以证据为导向的研究途径，结合结构化的相关人员访谈、技术文献的综合分析和交叉检验的检验通讯协定，得出可靠的结论。

本执行摘要的研究结合了结构化的初步研究、行业相关人员访谈以及系统的二手证据审查，以确保可靠的检验和可操作的结论。初步研究包括对生物技术公司和契约製造製造商的采购主管、品质和法规专业人员以及製程工程师，以及供应商组织的商业领导者进行深入访谈。这些访谈旨在揭示材料选择、灭菌方法选择和供应商资格认证时间表等方面的实际权衡取舍。

透过策略性地整合材料科学、供应链适应性和验证准备，为在生物製药製造领域获得竞争优势提供决定性措施。

先进的聚合物工程技术、检验的灭菌方法以及模组化配置选项的整合，使生物工艺袋成为现代生物製药生产策略的核心要素。将生物製程袋的选择视为材料科学、製程验证和供应链规划交叉领域的一项策略决策的企业，能够获得切实的营运效益，例如更快的合格週期和更高的製程稳定性。相反，低估材料相容性和灭菌方法之间的相互作用，则可能导致不必要的延误和品质风险。

目录

第一章：序言

第二章调查方法

  • 研究设计
  • 研究框架
  • 市场规模预测
  • 数据三角测量
  • 调查结果
  • 调查前提
  • 调查限制

第三章执行摘要

  • 首席主管观点
  • 市场规模和成长趋势
  • 2025年市占率分析
  • FPNV定位矩阵，2025
  • 新的商机
  • 下一代经营模式
  • 产业蓝图

第四章 市场概览

  • 产业生态系与价值链分析
  • 波特五力分析
  • PESTEL 分析
  • 市场展望
  • 上市策略

第五章 市场洞察

  • 消费者洞察与终端用户观点
  • 消费者体验基准
  • 机会地图
  • 分销通路分析
  • 价格趋势分析
  • 监理合规和标准框架
  • ESG与永续性分析
  • 中断和风险情景
  • 投资报酬率和成本效益分析

第六章：美国关税的累积影响，2025年

第七章：人工智慧的累积影响，2025年

第八章 生物工艺袋市场（依产品类型划分）

  • 收割袋
  • 媒体准备袋
  • 喜忧参半
  • 收纳袋
  • 运输袋

第九章 生物工艺袋市场（依材料类型划分）

  • 聚乙烯
    • 高密度聚苯乙烯
    • 低密度聚乙烯
  • 聚丙烯

第十章 生物工艺袋市场（依产品类型划分）

  • 双层
  • 多层
  • 单层

第十一章 依灭菌方法分類的生物工艺袋市场

  • 高压釜
  • 电子束
  • 环氧乙烷
  • 伽玛射线照射

第十二章 生物工艺袋市场依应用领域划分

  • 生物製药生产
  • 细胞培养
  • 基因治疗
  • 疫苗生产

第十三章 生物工艺袋市场（依最终用户划分）

  • 生技公司
  • 契约製造组织
  • 製药公司
  • 研究所

第十四章 各地区生物工艺袋市场

  • 美洲
    • 北美洲
    • 拉丁美洲
  • 欧洲、中东和非洲
    • 欧洲
    • 中东
    • 非洲
  • 亚太地区

第十五章 生物工艺袋市场（依组别划分）

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第十六章 各国生物工艺袋市场

  • 我们
  • 加拿大
  • 墨西哥
  • 巴西
  • 英国
  • 德国
  • 法国
  • 俄罗斯
  • 义大利
  • 西班牙
  • 中国
  • 印度
  • 日本
  • 澳洲
  • 韩国

第十七章：美国生物工艺袋市场

第十八章：中国生物工艺袋市场

第十九章 竞争情势

  • 市场集中度分析，2025年
    • 浓度比（CR）
    • 赫芬达尔-赫希曼指数 (HHI)
  • 近期趋势及影响分析，2025 年
  • 2025年产品系列分析
  • 基准分析，2025 年
  • ABEC, Inc.
  • Axygen, Inc.
  • Celltainer Biotech BV
  • Charter Medical, Ltd.
  • Colder Products Company
  • Corning Incorporated
  • Danaher Corporation
  • Distek, Inc.
  • FluoroLogiX
  • JMS Co., Ltd.
  • Kuhner Shaker GmbH
  • Lonza Group AG
  • Meissner Filtration Products, Inc.
  • Merck KGaA
  • Parker Hannifin Corporation
  • PBS Biotech, Inc.
  • Saint-Gobain SA
  • Sartorius AG
  • Thermo Fisher Scientific Inc.
Product Code: MRR-4F7A6D4FB8C7

The Bioprocess Bags Market was valued at USD 4.58 billion in 2025 and is projected to grow to USD 5.09 billion in 2026, with a CAGR of 13.67%, reaching USD 11.24 billion by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 4.58 billion
Estimated Year [2026] USD 5.09 billion
Forecast Year [2032] USD 11.24 billion
CAGR (%) 13.67%

A concise orientation to modern bioprocess bag technology and design imperatives that bridge materials, sterilization, and manufacturing agility

The evolution of single-use technologies in biologics production has elevated bioprocess bags from ancillary consumables to critical enablers of flexible, scalable, and contamination-controlled manufacturing. This introduction frames the contemporary landscape by connecting material science advances, configuration design choices, sterilization requirements, and regulatory expectations with operational priorities such as minimizing downtime, reducing cross-contamination risk, and enabling rapid product changeovers.

As biologics developers and contract manufacturers pursue faster time-to-clinic pathways, the role of bioprocess bags in upstream and downstream workflows becomes increasingly strategic. Material selection and barrier performance directly influence process compatibility with cell culture, gene therapy, and vaccine workflows. Concurrently, manufacturing architecture decisions-whether to deploy single-layer films for low-risk tasks or multi-layer and dual-layer constructions for high-integrity fluid handling-reflect a balance between cost-efficiency and risk mitigation.

Regulatory scrutiny and quality system demands also shape procurement and validation strategies. Sterilization method compatibility, traceability, and extractables and leachables profiling are now routine considerations embedded early in supplier qualification. Taken together, these forces position bioprocess bags as a junction between supply chain resilience and biomanufacturing agility, and this report introduction situates the reader to understand how discrete technical choices cascade into operational and commercial outcomes.

Emerging technological and procedural trends reshaping bioprocess bag materials, sterilization practices, and configuration choices across biologics manufacturing

Bioprocess bag technologies are experiencing transformative shifts driven by cross-cutting advances in polymer engineering, sterilization capabilities, and user-driven configuration preferences. Innovations in high-performance polyethylene and polypropylene formulations, combined with multilayer coextrusion and enhanced welding techniques, are improving mechanical strength and chemical resistance while simplifying aseptic transfer operations. These material and process innovations reduce the need for hard-piped systems in many contexts, enabling more modular and distributed manufacturing footprints.

Sterilization science is also evolving, with electron beam and gamma radiation methods increasingly applied alongside established autoclave and ethylene oxide protocols to meet diverse product needs. The selection of sterilization methods now reflects not only sterility assurance but also concerns about polymer stability and regulatory acceptance for specific biologic classes. As a result, suppliers are offering validated compatibility data and tighter control over extractables and leachables to accelerate user qualification processes.

Market dynamics show a preference for configurable bag architectures that support single-use workflows across upstream and downstream operations. Dual-layer and multi-layer configurations are gaining adoption where chemical resistance or barrier performance is paramount, whereas single-layer bags remain relevant for lower-risk storage and transfer tasks. Overall, the landscape is shifting toward integrated systems thinking, where bag design, sterilization, and supply chain strategy are considered holistically to support faster product transitions and higher process reliability.

How forthcoming tariff adjustments are prompting supply chain redesigns, nearshoring considerations, and procurement playbooks to protect biologics manufacturing continuity

The introduction of new tariff measures announced for implementation in the United States in 2025 has prompted biomanufacturers and suppliers to reassess supply chain resilience, sourcing strategies, and cost pass-through mechanisms. Tariff-driven import cost adjustments exert pressure on decision cycles related to supplier selection, inventory buffers, and the geographic diversification of raw material procurement. For manufacturers reliant on imported films, fittings, or finished bags, the tariffs create an imperative to evaluate nearshoring, dual-sourcing, and inventory optimization tactics to preserve production continuity.

In response, many stakeholders are intensifying supplier qualification activities to identify partners with regional manufacturing capabilities or bonded warehousing that can mitigate tariff exposure. This has accelerated conversations about establishing local extrusion and conversion capacity in proximity to major biologics hubs, and it has reinforced the attractiveness of vertically integrated suppliers that control upstream polymer sourcing. At the same time, procurement teams are refining total landed cost models to include tariff scenarios, duty drawback processes, and tariff-engineered invoice strategies that minimize margin erosion without compromising compliance.

Regulatory and customs compliance remains a parallel consideration; changes to tariff schedules necessitate updated documentation flows, HS code classification reviews, and proactive customs engagement to prevent shipment delays. The combined effect is a heightened focus on agility: organizations that rapidly adapt contracts, logistics, and supplier footprints will be better positioned to manage cost volatility while safeguarding manufacturing timelines and product quality.

An analytic view into how volume tiers, product types, applications, end users, material science, configurations, and sterilization choices shape procurement and validation pathways

A granular segmentation lens reveals differentiated dynamics across volume tiers, product types, end-use applications, and materials, each influencing procurement, validation, and inventory strategies. Volume categories ranging from very small 0-10 liter bags through intermediate 10-50 liter sizes and into larger greater-than-50 liter formats determine not only handling and storage practices but also connector selection and process scale-up planning. Lower-volume bags are commonly associated with development and clinical workflows where flexibility and rapid turnover are priorities, while larger-volume formats align with commercial-scale operations and pose distinct logistics and storage challenges.

Product-type distinctions such as harvest bags, media preparation bags, mixing bags, storage bags, and transfer bags map to unique functional requirements and regulatory expectations. Harvest bags require robust particulate control and fluid clarity management; media preparation bags emphasize sterility and chemical compatibility; mixing bags prioritize uniform shear profiles and robust weld integrity; storage bags focus on long-term containment and permeability characteristics; transfer bags demand secure connectors and simplified aseptic transfer mechanisms. These product-level requirements intersect with application areas-biopharmaceutical production, cell culture, gene therapy, and vaccine production-where sensitivity to extractables, regulatory scrutiny, and process repeatability differ markedly.

End-user categories including biotechnology companies, contract manufacturing organizations, pharmaceutical companies, and research institutes exhibit varying procurement cadences and validation rigor. Biotechnology companies and pharmaceutical firms often emphasize long-term supplier relationships and deep extractables data, whereas contract manufacturers require flexible supply arrangements to serve multiple clients. Research institutes may favor smaller volumes and rapid delivery. Material choices between polyethylene and polypropylene, and within polyethylene between high-density and low-density variants, inform barrier performance, process compatibility, and sterilization tolerance. Configuration options such as dual layer, multi layer, and single layer constructions further refine performance trade-offs between cost and protection. Finally, sterilization method selection-autoclave, electron beam, ethylene oxide, or gamma radiation-must align with both material stability and the intended application to ensure sterility assurance without compromising polymer integrity.

How regional manufacturing hubs, regulatory regimes, and supply chain infrastructures drive differentiated adoption and sourcing strategies across global bioprocess bag markets

Regional dynamics shape supply chain architecture, regulatory engagement, and adoption velocity in different ways across the Americas, Europe Middle East and Africa, and Asia Pacific economic spaces. In the Americas, proximity to major biotech clusters and a mature contract manufacturing ecosystem drive high adoption of advanced single-use systems and a preference for suppliers offering robust validation packages. This region emphasizes speed to clinic and benefits from logistics infrastructure that supports rapid distribution of bag assemblies and replacement components.

Across Europe, the Middle East and Africa, regulatory harmonization efforts and stringent quality expectations influence adoption curves. Manufacturers and end users in this broader geography often prioritize traceability, conformity to regional standards, and partnerships with suppliers that can demonstrate compliance across diverse regulatory regimes. In certain markets within this region, there is also a growing focus on circularity and end-of-life considerations for single-use plastics, prompting discussions on recycling and responsible disposal pathways.

The Asia Pacific region exhibits significant heterogeneity, with rapid expansion of biopharma capacity in key markets and growing local manufacturing capability for both films and finished bag assemblies. This expansion is coupled with an increasing emphasis on domestic supplier qualification and cost competitiveness, as well as evolving regulatory frameworks that demand localized data for extractables and sterility validation. Across all regions, differences in tariff exposure, logistics lead times, and supplier ecosystems influence strategic decisions about inventory buffers, supplier diversification, and manufacturing siting.

How technology differentiation, vertical integration, and service oriented partnerships are defining competitive advantage and supplier selection criteria in the industry

Competitive dynamics within the bioprocess bag arena are characterized by a combination of technical differentiation, vertical integration, strategic partnerships, and service-led value propositions. Leading suppliers that invest in polymer science, validated sterilization protocols, and comprehensive extractables and leachables data create defensible positions that appeal to high-regulation end users. At the same time, companies that integrate upstream film extrusion with downstream conversion capabilities reduce lead times and improve quality control, creating a compelling narrative for customers prioritizing supply continuity.

Strategic partnerships between material scientists, contract manufacturers, and end users are increasingly common, enabling co-development of bespoke solutions for sensitive applications such as gene therapy and viral vector production. These collaborations often accelerate validation cycles by providing shared data packages and enabling on-site compatibility testing. In parallel, some suppliers are expanding into adjacent services such as aseptic transfer components, connector systems, and validated assemblies to present a more integrated solution set, thereby increasing switching costs for customers.

Investment in regulatory sciences, including robust extractables and leachables profiling, sterility validation across multiple sterilization modalities, and digital traceability, differentiates companies that target large pharmaceutical and contract manufacturing customers. Service offerings such as rapid-response supply programs, regional warehousing, and technical training further reinforce competitive advantage and support deeper customer relationships.

Practical strategies to fortify supply resilience, accelerate validation readiness, and expand service capabilities that materially reduce risk and enhance customer retention

Industry leaders should pursue a threefold strategy that concurrently strengthens supply resilience, accelerates technical validation capabilities, and deepens customer service models to capture opportunity and mitigate disruption. First, diversify supply chains by qualifying multiple film and conversion partners across geographies and by exploring nearshoring opportunities for critical components to reduce tariff and logistics exposure. This should be combined with strategic inventory policies that optimize buffer stocks for long-lead items while avoiding unnecessary working capital strain.

Second, invest in validation accelerators such as standardized extractables and leachables datasets, cross-validated sterilization protocols, and digital documentation platforms that streamline qualification for end users. Suppliers and manufacturers that preemptively provide high-quality technical dossiers and validation kits can materially reduce time-to-use for customers, creating a commercial edge. Third, expand service-oriented offerings that include modular assemblies, on-demand technical training, and responsive regional support to enhance customer retention and reduce switching costs.

Finally, align product roadmaps with sustainability and circularity considerations by exploring film formulations that enable lower environmental impact and by participating in industry initiatives that address responsible disposal. Coupled with proactive engagement on regulatory and tariff developments, these actions will help organizations remain competitive while adapting to evolving market and policy conditions.

An evidence driven research approach blending structured stakeholder interviews, technical literature synthesis, and cross verified validation protocols for dependable conclusions

The research underpinning this executive summary combines structured primary engagement with industry stakeholders and methodical secondary evidence review to ensure robust triangulation and actionable conclusions. Primary research comprised in-depth interviews with procurement leads, quality and regulatory experts, process engineers at biotechnology companies and contract manufacturers, and commercial leaders across supplier organizations. These interviews were designed to illuminate real-world trade-offs in material selection, sterilization choices, and supplier qualification timelines.

Secondary research synthesized publicly available technical literature, regulatory guidance documents, patent filings, and supplier technical white papers to map material innovations, sterilization compatibility issues, and configuration trends. Data validation included cross-referencing interview insights with supplier validation documents and industry guidance to confirm consistency and identify divergence. Analytical methods included segmentation mapping, scenario analysis for tariff impacts, and qualitative benchmarking across service offerings and technical dossiers.

Quality assurance measures consisted of iterative review cycles with domain experts, verification of critical technical assertions against multiple independent sources, and adherence to a documented audit trail for all reference material. The result is a consolidated evidence base that supports the observations and recommendations presented here while preserving confidentiality and commercial sensitivity for participating stakeholders.

A strategic synthesis of material science, supply chain adaptability, and validation readiness that highlights decisive actions for securing operational advantage in biologics production

The integration of advanced polymer engineering, validated sterilization approaches, and modular configuration options positions bioprocess bags as a pivotal component in modern biologics manufacturing strategies. Organizations that treat bag selection as a strategic choice-one that intersects material science, process validation, and supply chain planning-will realize tangible operational benefits including faster qualification cycles and greater process robustness. Conversely, underestimating the interplay of material compatibility and sterilization method can introduce avoidable delays and quality risks.

Tariff dynamics and regional supply chain variations underscore the need for proactive procurement planning and supplier diversification. Companies that invest in validation accelerators and build deeper partnerships with suppliers will be better positioned to manage cost volatility without compromising compliance or timelines. Finally, competitive differentiation increasingly hinges not just on product specifications but on the completeness of technical documentation, responsiveness of regional support networks, and the ability to co-develop solutions for emerging modalities such as gene therapy and viral vector manufacturing.

In sum, the sector is moving toward integrated solutions that marry technical rigor with supply chain intelligence, and organizations that align product roadmaps, validation capabilities, and commercial support models will capture outsized operational and strategic advantages.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Porter's Five Forces Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Market Outlook
    • 4.5.1. Near-Term Market Outlook (0-2 Years)
    • 4.5.2. Medium-Term Market Outlook (3-5 Years)
    • 4.5.3. Long-Term Market Outlook (5-10 Years)
  • 4.6. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Bioprocess Bags Market, by Product Type

  • 8.1. Harvest Bags
  • 8.2. Media Preparation Bags
  • 8.3. Mixing Bags
  • 8.4. Storage Bags
  • 8.5. Transfer Bags

9. Bioprocess Bags Market, by Material Type

  • 9.1. Polyethylene
    • 9.1.1. High-Density Polyethylene
    • 9.1.2. Low-Density Polyethylene
  • 9.2. Polypropylene

10. Bioprocess Bags Market, by Configuration

  • 10.1. Dual Layer
  • 10.2. Multi Layer
  • 10.3. Single Layer

11. Bioprocess Bags Market, by Sterilization Method

  • 11.1. Autoclave
  • 11.2. Electron Beam
  • 11.3. Ethylene Oxide
  • 11.4. Gamma Radiation

12. Bioprocess Bags Market, by Application

  • 12.1. Biopharmaceutical Production
  • 12.2. Cell Culture
  • 12.3. Gene Therapy
  • 12.4. Vaccine Production

13. Bioprocess Bags Market, by End User

  • 13.1. Biotechnology Companies
  • 13.2. Contract Manufacturing Organizations
  • 13.3. Pharmaceutical Companies
  • 13.4. Research Institutes

14. Bioprocess Bags Market, by Region

  • 14.1. Americas
    • 14.1.1. North America
    • 14.1.2. Latin America
  • 14.2. Europe, Middle East & Africa
    • 14.2.1. Europe
    • 14.2.2. Middle East
    • 14.2.3. Africa
  • 14.3. Asia-Pacific

15. Bioprocess Bags Market, by Group

  • 15.1. ASEAN
  • 15.2. GCC
  • 15.3. European Union
  • 15.4. BRICS
  • 15.5. G7
  • 15.6. NATO

16. Bioprocess Bags Market, by Country

  • 16.1. United States
  • 16.2. Canada
  • 16.3. Mexico
  • 16.4. Brazil
  • 16.5. United Kingdom
  • 16.6. Germany
  • 16.7. France
  • 16.8. Russia
  • 16.9. Italy
  • 16.10. Spain
  • 16.11. China
  • 16.12. India
  • 16.13. Japan
  • 16.14. Australia
  • 16.15. South Korea

17. United States Bioprocess Bags Market

18. China Bioprocess Bags Market

19. Competitive Landscape

  • 19.1. Market Concentration Analysis, 2025
    • 19.1.1. Concentration Ratio (CR)
    • 19.1.2. Herfindahl Hirschman Index (HHI)
  • 19.2. Recent Developments & Impact Analysis, 2025
  • 19.3. Product Portfolio Analysis, 2025
  • 19.4. Benchmarking Analysis, 2025
  • 19.5. ABEC, Inc.
  • 19.6. Axygen, Inc.
  • 19.7. Celltainer Biotech BV
  • 19.8. Charter Medical, Ltd.
  • 19.9. Colder Products Company
  • 19.10. Corning Incorporated
  • 19.11. Danaher Corporation
  • 19.12. Distek, Inc.
  • 19.13. FluoroLogiX
  • 19.14. JMS Co., Ltd.
  • 19.15. Kuhner Shaker GmbH
  • 19.16. Lonza Group AG
  • 19.17. Meissner Filtration Products, Inc.
  • 19.18. Merck KGaA
  • 19.19. Parker Hannifin Corporation
  • 19.20. PBS Biotech, Inc.
  • 19.21. Saint-Gobain S.A.
  • 19.22. Sartorius AG
  • 19.23. Thermo Fisher Scientific Inc.

LIST OF FIGURES

  • FIGURE 1. GLOBAL BIOPROCESS BAGS MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL BIOPROCESS BAGS MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 3. GLOBAL BIOPROCESS BAGS MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 4. GLOBAL BIOPROCESS BAGS MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 5. GLOBAL BIOPROCESS BAGS MARKET SIZE, BY MATERIAL TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL BIOPROCESS BAGS MARKET SIZE, BY CONFIGURATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 7. GLOBAL BIOPROCESS BAGS MARKET SIZE, BY STERILIZATION METHOD, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL BIOPROCESS BAGS MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 9. GLOBAL BIOPROCESS BAGS MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL BIOPROCESS BAGS MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 11. GLOBAL BIOPROCESS BAGS MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 12. GLOBAL BIOPROCESS BAGS MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 13. UNITED STATES BIOPROCESS BAGS MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 14. CHINA BIOPROCESS BAGS MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL BIOPROCESS BAGS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL BIOPROCESS BAGS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL BIOPROCESS BAGS MARKET SIZE, BY HARVEST BAGS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL BIOPROCESS BAGS MARKET SIZE, BY HARVEST BAGS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL BIOPROCESS BAGS MARKET SIZE, BY HARVEST BAGS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL BIOPROCESS BAGS MARKET SIZE, BY MEDIA PREPARATION BAGS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL BIOPROCESS BAGS MARKET SIZE, BY MEDIA PREPARATION BAGS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL BIOPROCESS BAGS MARKET SIZE, BY MEDIA PREPARATION BAGS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL BIOPROCESS BAGS MARKET SIZE, BY MIXING BAGS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL BIOPROCESS BAGS MARKET SIZE, BY MIXING BAGS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL BIOPROCESS BAGS MARKET SIZE, BY MIXING BAGS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL BIOPROCESS BAGS MARKET SIZE, BY STORAGE BAGS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL BIOPROCESS BAGS MARKET SIZE, BY STORAGE BAGS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL BIOPROCESS BAGS MARKET SIZE, BY STORAGE BAGS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL BIOPROCESS BAGS MARKET SIZE, BY TRANSFER BAGS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL BIOPROCESS BAGS MARKET SIZE, BY TRANSFER BAGS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL BIOPROCESS BAGS MARKET SIZE, BY TRANSFER BAGS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL BIOPROCESS BAGS MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL BIOPROCESS BAGS MARKET SIZE, BY POLYETHYLENE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL BIOPROCESS BAGS MARKET SIZE, BY POLYETHYLENE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL BIOPROCESS BAGS MARKET SIZE, BY POLYETHYLENE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL BIOPROCESS BAGS MARKET SIZE, BY POLYETHYLENE, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL BIOPROCESS BAGS MARKET SIZE, BY HIGH-DENSITY POLYETHYLENE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL BIOPROCESS BAGS MARKET SIZE, BY HIGH-DENSITY POLYETHYLENE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL BIOPROCESS BAGS MARKET SIZE, BY HIGH-DENSITY POLYETHYLENE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL BIOPROCESS BAGS MARKET SIZE, BY LOW-DENSITY POLYETHYLENE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL BIOPROCESS BAGS MARKET SIZE, BY LOW-DENSITY POLYETHYLENE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL BIOPROCESS BAGS MARKET SIZE, BY LOW-DENSITY POLYETHYLENE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL BIOPROCESS BAGS MARKET SIZE, BY POLYPROPYLENE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL BIOPROCESS BAGS MARKET SIZE, BY POLYPROPYLENE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL BIOPROCESS BAGS MARKET SIZE, BY POLYPROPYLENE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL BIOPROCESS BAGS MARKET SIZE, BY CONFIGURATION, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL BIOPROCESS BAGS MARKET SIZE, BY DUAL LAYER, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL BIOPROCESS BAGS MARKET SIZE, BY DUAL LAYER, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL BIOPROCESS BAGS MARKET SIZE, BY DUAL LAYER, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL BIOPROCESS BAGS MARKET SIZE, BY MULTI LAYER, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL BIOPROCESS BAGS MARKET SIZE, BY MULTI LAYER, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL BIOPROCESS BAGS MARKET SIZE, BY MULTI LAYER, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL BIOPROCESS BAGS MARKET SIZE, BY SINGLE LAYER, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL BIOPROCESS BAGS MARKET SIZE, BY SINGLE LAYER, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL BIOPROCESS BAGS MARKET SIZE, BY SINGLE LAYER, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL BIOPROCESS BAGS MARKET SIZE, BY STERILIZATION METHOD, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL BIOPROCESS BAGS MARKET SIZE, BY AUTOCLAVE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL BIOPROCESS BAGS MARKET SIZE, BY AUTOCLAVE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL BIOPROCESS BAGS MARKET SIZE, BY AUTOCLAVE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL BIOPROCESS BAGS MARKET SIZE, BY ELECTRON BEAM, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL BIOPROCESS BAGS MARKET SIZE, BY ELECTRON BEAM, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL BIOPROCESS BAGS MARKET SIZE, BY ELECTRON BEAM, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL BIOPROCESS BAGS MARKET SIZE, BY ETHYLENE OXIDE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL BIOPROCESS BAGS MARKET SIZE, BY ETHYLENE OXIDE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL BIOPROCESS BAGS MARKET SIZE, BY ETHYLENE OXIDE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL BIOPROCESS BAGS MARKET SIZE, BY GAMMA RADIATION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL BIOPROCESS BAGS MARKET SIZE, BY GAMMA RADIATION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL BIOPROCESS BAGS MARKET SIZE, BY GAMMA RADIATION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL BIOPROCESS BAGS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL BIOPROCESS BAGS MARKET SIZE, BY BIOPHARMACEUTICAL PRODUCTION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL BIOPROCESS BAGS MARKET SIZE, BY BIOPHARMACEUTICAL PRODUCTION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL BIOPROCESS BAGS MARKET SIZE, BY BIOPHARMACEUTICAL PRODUCTION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL BIOPROCESS BAGS MARKET SIZE, BY CELL CULTURE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL BIOPROCESS BAGS MARKET SIZE, BY CELL CULTURE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL BIOPROCESS BAGS MARKET SIZE, BY CELL CULTURE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL BIOPROCESS BAGS MARKET SIZE, BY GENE THERAPY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 63. GLOBAL BIOPROCESS BAGS MARKET SIZE, BY GENE THERAPY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 64. GLOBAL BIOPROCESS BAGS MARKET SIZE, BY GENE THERAPY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 65. GLOBAL BIOPROCESS BAGS MARKET SIZE, BY VACCINE PRODUCTION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 66. GLOBAL BIOPROCESS BAGS MARKET SIZE, BY VACCINE PRODUCTION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 67. GLOBAL BIOPROCESS BAGS MARKET SIZE, BY VACCINE PRODUCTION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 68. GLOBAL BIOPROCESS BAGS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 69. GLOBAL BIOPROCESS BAGS MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 70. GLOBAL BIOPROCESS BAGS MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 71. GLOBAL BIOPROCESS BAGS MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 72. GLOBAL BIOPROCESS BAGS MARKET SIZE, BY CONTRACT MANUFACTURING ORGANIZATIONS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 73. GLOBAL BIOPROCESS BAGS MARKET SIZE, BY CONTRACT MANUFACTURING ORGANIZATIONS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 74. GLOBAL BIOPROCESS BAGS MARKET SIZE, BY CONTRACT MANUFACTURING ORGANIZATIONS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 75. GLOBAL BIOPROCESS BAGS MARKET SIZE, BY PHARMACEUTICAL COMPANIES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 76. GLOBAL BIOPROCESS BAGS MARKET SIZE, BY PHARMACEUTICAL COMPANIES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 77. GLOBAL BIOPROCESS BAGS MARKET SIZE, BY PHARMACEUTICAL COMPANIES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 78. GLOBAL BIOPROCESS BAGS MARKET SIZE, BY RESEARCH INSTITUTES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 79. GLOBAL BIOPROCESS BAGS MARKET SIZE, BY RESEARCH INSTITUTES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 80. GLOBAL BIOPROCESS BAGS MARKET SIZE, BY RESEARCH INSTITUTES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 81. GLOBAL BIOPROCESS BAGS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 82. AMERICAS BIOPROCESS BAGS MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 83. AMERICAS BIOPROCESS BAGS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 84. AMERICAS BIOPROCESS BAGS MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 85. AMERICAS BIOPROCESS BAGS MARKET SIZE, BY POLYETHYLENE, 2018-2032 (USD MILLION)
  • TABLE 86. AMERICAS BIOPROCESS BAGS MARKET SIZE, BY CONFIGURATION, 2018-2032 (USD MILLION)
  • TABLE 87. AMERICAS BIOPROCESS BAGS MARKET SIZE, BY STERILIZATION METHOD, 2018-2032 (USD MILLION)
  • TABLE 88. AMERICAS BIOPROCESS BAGS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 89. AMERICAS BIOPROCESS BAGS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 90. NORTH AMERICA BIOPROCESS BAGS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 91. NORTH AMERICA BIOPROCESS BAGS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 92. NORTH AMERICA BIOPROCESS BAGS MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 93. NORTH AMERICA BIOPROCESS BAGS MARKET SIZE, BY POLYETHYLENE, 2018-2032 (USD MILLION)
  • TABLE 94. NORTH AMERICA BIOPROCESS BAGS MARKET SIZE, BY CONFIGURATION, 2018-2032 (USD MILLION)
  • TABLE 95. NORTH AMERICA BIOPROCESS BAGS MARKET SIZE, BY STERILIZATION METHOD, 2018-2032 (USD MILLION)
  • TABLE 96. NORTH AMERICA BIOPROCESS BAGS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 97. NORTH AMERICA BIOPROCESS BAGS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 98. LATIN AMERICA BIOPROCESS BAGS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 99. LATIN AMERICA BIOPROCESS BAGS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 100. LATIN AMERICA BIOPROCESS BAGS MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 101. LATIN AMERICA BIOPROCESS BAGS MARKET SIZE, BY POLYETHYLENE, 2018-2032 (USD MILLION)
  • TABLE 102. LATIN AMERICA BIOPROCESS BAGS MARKET SIZE, BY CONFIGURATION, 2018-2032 (USD MILLION)
  • TABLE 103. LATIN AMERICA BIOPROCESS BAGS MARKET SIZE, BY STERILIZATION METHOD, 2018-2032 (USD MILLION)
  • TABLE 104. LATIN AMERICA BIOPROCESS BAGS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 105. LATIN AMERICA BIOPROCESS BAGS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 106. EUROPE, MIDDLE EAST & AFRICA BIOPROCESS BAGS MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 107. EUROPE, MIDDLE EAST & AFRICA BIOPROCESS BAGS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 108. EUROPE, MIDDLE EAST & AFRICA BIOPROCESS BAGS MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 109. EUROPE, MIDDLE EAST & AFRICA BIOPROCESS BAGS MARKET SIZE, BY POLYETHYLENE, 2018-2032 (USD MILLION)
  • TABLE 110. EUROPE, MIDDLE EAST & AFRICA BIOPROCESS BAGS MARKET SIZE, BY CONFIGURATION, 2018-2032 (USD MILLION)
  • TABLE 111. EUROPE, MIDDLE EAST & AFRICA BIOPROCESS BAGS MARKET SIZE, BY STERILIZATION METHOD, 2018-2032 (USD MILLION)
  • TABLE 112. EUROPE, MIDDLE EAST & AFRICA BIOPROCESS BAGS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 113. EUROPE, MIDDLE EAST & AFRICA BIOPROCESS BAGS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 114. EUROPE BIOPROCESS BAGS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 115. EUROPE BIOPROCESS BAGS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 116. EUROPE BIOPROCESS BAGS MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 117. EUROPE BIOPROCESS BAGS MARKET SIZE, BY POLYETHYLENE, 2018-2032 (USD MILLION)
  • TABLE 118. EUROPE BIOPROCESS BAGS MARKET SIZE, BY CONFIGURATION, 2018-2032 (USD MILLION)
  • TABLE 119. EUROPE BIOPROCESS BAGS MARKET SIZE, BY STERILIZATION METHOD, 2018-2032 (USD MILLION)
  • TABLE 120. EUROPE BIOPROCESS BAGS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 121. EUROPE BIOPROCESS BAGS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 122. MIDDLE EAST BIOPROCESS BAGS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 123. MIDDLE EAST BIOPROCESS BAGS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 124. MIDDLE EAST BIOPROCESS BAGS MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 125. MIDDLE EAST BIOPROCESS BAGS MARKET SIZE, BY POLYETHYLENE, 2018-2032 (USD MILLION)
  • TABLE 126. MIDDLE EAST BIOPROCESS BAGS MARKET SIZE, BY CONFIGURATION, 2018-2032 (USD MILLION)
  • TABLE 127. MIDDLE EAST BIOPROCESS BAGS MARKET SIZE, BY STERILIZATION METHOD, 2018-2032 (USD MILLION)
  • TABLE 128. MIDDLE EAST BIOPROCESS BAGS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 129. MIDDLE EAST BIOPROCESS BAGS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 130. AFRICA BIOPROCESS BAGS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 131. AFRICA BIOPROCESS BAGS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 132. AFRICA BIOPROCESS BAGS MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 133. AFRICA BIOPROCESS BAGS MARKET SIZE, BY POLYETHYLENE, 2018-2032 (USD MILLION)
  • TABLE 134. AFRICA BIOPROCESS BAGS MARKET SIZE, BY CONFIGURATION, 2018-2032 (USD MILLION)
  • TABLE 135. AFRICA BIOPROCESS BAGS MARKET SIZE, BY STERILIZATION METHOD, 2018-2032 (USD MILLION)
  • TABLE 136. AFRICA BIOPROCESS BAGS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 137. AFRICA BIOPROCESS BAGS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 138. ASIA-PACIFIC BIOPROCESS BAGS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 139. ASIA-PACIFIC BIOPROCESS BAGS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 140. ASIA-PACIFIC BIOPROCESS BAGS MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 141. ASIA-PACIFIC BIOPROCESS BAGS MARKET SIZE, BY POLYETHYLENE, 2018-2032 (USD MILLION)
  • TABLE 142. ASIA-PACIFIC BIOPROCESS BAGS MARKET SIZE, BY CONFIGURATION, 2018-2032 (USD MILLION)
  • TABLE 143. ASIA-PACIFIC BIOPROCESS BAGS MARKET SIZE, BY STERILIZATION METHOD, 2018-2032 (USD MILLION)
  • TABLE 144. ASIA-PACIFIC BIOPROCESS BAGS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 145. ASIA-PACIFIC BIOPROCESS BAGS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 146. GLOBAL BIOPROCESS BAGS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 147. ASEAN BIOPROCESS BAGS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 148. ASEAN BIOPROCESS BAGS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 149. ASEAN BIOPROCESS BAGS MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 150. ASEAN BIOPROCESS BAGS MARKET SIZE, BY POLYETHYLENE, 2018-2032 (USD MILLION)
  • TABLE 151. ASEAN BIOPROCESS BAGS MARKET SIZE, BY CONFIGURATION, 2018-2032 (USD MILLION)
  • TABLE 152. ASEAN BIOPROCESS BAGS MARKET SIZE, BY STERILIZATION METHOD, 2018-2032 (USD MILLION)
  • TABLE 153. ASEAN BIOPROCESS BAGS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 154. ASEAN BIOPROCESS BAGS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 155. GCC BIOPROCESS BAGS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 156. GCC BIOPROCESS BAGS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 157. GCC BIOPROCESS BAGS MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 158. GCC BIOPROCESS BAGS MARKET SIZE, BY POLYETHYLENE, 2018-2032 (USD MILLION)
  • TABLE 159. GCC BIOPROCESS BAGS MARKET SIZE, BY CONFIGURATION, 2018-2032 (USD MILLION)
  • TABLE 160. GCC BIOPROCESS BAGS MARKET SIZE, BY STERILIZATION METHOD, 2018-2032 (USD MILLION)
  • TABLE 161. GCC BIOPROCESS BAGS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 162. GCC BIOPROCESS BAGS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 163. EUROPEAN UNION BIOPROCESS BAGS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 164. EUROPEAN UNION BIOPROCESS BAGS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 165. EUROPEAN UNION BIOPROCESS BAGS MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 166. EUROPEAN UNION BIOPROCESS BAGS MARKET SIZE, BY POLYETHYLENE, 2018-2032 (USD MILLION)
  • TABLE 167. EUROPEAN UNION BIOPROCESS BAGS MARKET SIZE, BY CONFIGURATION, 2018-2032 (USD MILLION)
  • TABLE 168. EUROPEAN UNION BIOPROCESS BAGS MARKET SIZE, BY STERILIZATION METHOD, 2018-2032 (USD MILLION)
  • TABLE 169. EUROPEAN UNION BIOPROCESS BAGS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 170. EUROPEAN UNION BIOPROCESS BAGS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 171. BRICS BIOPROCESS BAGS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 172. BRICS BIOPROCESS BAGS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 173. BRICS BIOPROCESS BAGS MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 174. BRICS BIOPROCESS BAGS MARKET SIZE, BY POLYETHYLENE, 2018-2032 (USD MILLION)
  • TABLE 175. BRICS BIOPROCESS BAGS MARKET SIZE, BY CONFIGURATION, 2018-2032 (USD MILLION)
  • TABLE 176. BRICS BIOPROCESS BAGS MARKET SIZE, BY STERILIZATION METHOD, 2018-2032 (USD MILLION)
  • TABLE 177. BRICS BIOPROCESS BAGS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 178. BRICS BIOPROCESS BAGS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 179. G7 BIOPROCESS BAGS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 180. G7 BIOPROCESS BAGS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 181. G7 BIOPROCESS BAGS MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 182. G7 BIOPROCESS BAGS MARKET SIZE, BY POLYETHYLENE, 2018-2032 (USD MILLION)
  • TABLE 183. G7 BIOPROCESS BAGS MARKET SIZE, BY CONFIGURATION, 2018-2032 (USD MILLION)
  • TABLE 184. G7 BIOPROCESS BAGS MARKET SIZE, BY STERILIZATION METHOD, 2018-2032 (USD MILLION)
  • TABLE 185. G7 BIOPROCESS BAGS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 186. G7 BIOPROCESS BAGS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 187. NATO BIOPROCESS BAGS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 188. NATO BIOPROCESS BAGS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 189. NATO BIOPROCESS BAGS MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 190. NATO BIOPROCESS BAGS MARKET SIZE, BY POLYETHYLENE, 2018-2032 (USD MILLION)
  • TABLE 191. NATO BIOPROCESS BAGS MARKET SIZE, BY CONFIGURATION, 2018-2032 (USD MILLION)
  • TABLE 192. NATO BIOPROCESS BAGS MARKET SIZE, BY STERILIZATION METHOD, 2018-2032 (USD MILLION)
  • TABLE 193. NATO BIOPROCESS BAGS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 194. NATO BIOPROCESS BAGS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 195. GLOBAL BIOPROCESS BAGS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 196. UNITED STATES BIOPROCESS BAGS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 197. UNITED STATES BIOPROCESS BAGS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 198. UNITED STATES BIOPROCESS BAGS MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 199. UNITED STATES BIOPROCESS BAGS MARKET SIZE, BY POLYETHYLENE, 2018-2032 (USD MILLION)
  • TABLE 200. UNITED STATES BIOPROCESS BAGS MARKET SIZE, BY CONFIGURATION, 2018-2032 (USD MILLION)
  • TABLE 201. UNITED STATES BIOPROCESS BAGS MARKET SIZE, BY STERILIZATION METHOD, 2018-2032 (USD MILLION)
  • TABLE 202. UNITED STATES BIOPROCESS BAGS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 203. UNITED STATES BIOPROCESS BAGS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 204. CHINA BIOPROCESS BAGS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 205. CHINA BIOPROCESS BAGS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 206. CHINA BIOPROCESS BAGS MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 207. CHINA BIOPROCESS BAGS MARKET SIZE, BY POLYETHYLENE, 2018-2032 (USD MILLION)
  • TABLE 208. CHINA BIOPROCESS BAGS MARKET SIZE, BY CONFIGURATION, 2018-2032 (USD MILLION)
  • TABLE 209. CHINA BIOPROCESS BAGS MARKET SIZE, BY STERILIZATION METHOD, 2018-2032 (USD MILLION)
  • TABLE 210. CHINA BIOPROCESS BAGS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 211. CHINA BIOPROCESS BAGS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)